A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

Phase 1/2 Unknown 100 enrolled Chaitanya Hospital, Pune

NaSingle-groupOpen-labelTreatment

Summary

This clinical trial is a single Arm, single centre to check the safety and efficacy of bone marrow derived autologous mono nuclear cells (MNC) (100 million per dose). Trial to be conducted for 36 months.

Timeline

Start: 2014-09
Primary completion: 2016-06
Completion: 2016-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MNC	Cell therapy	1e+08 cells	Intrathecal

A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

Summary

Timeline

Drugs

Indications